
Using zebrafish to study metabolic adverse outcomes of EDCs and associated mechanisms
In October 2024, the Wincent Lab at Karolinska Institutet started testing the effects of NEMESIS focus-compounds on adverse outcomes using zebrafish, a non-mammalian model, as part of the in vivo work done in the NEMESIS project. Malin Lundvall, a Master’s student, and Oscar Diaz, Postdoc, performed the initial testing and evaluated the effects of 8 […]

NEMESIS project meeting in Barcelona 29-30 January 2025
NEMESIS has run for just over one year and it was time to see where the project is at. The consortium members met at a General Assembly meeting in Barcelona on 29-30 January 2025 to discuss the progress of the project and the next steps. The meeting was arranged at CSIC Spanish National Research Council […]

Subscribe the ENKORE newsletter
Subscribe now to receive in your inbox the ENKORE Cluster newsletter on the latest news and advances on the health impacts of endocrine-disrupting chemicals from European research institutions and five Horizon Europe funded projects: NEMESIS as well as EDC-MASLD, ENDOMIX, HYPIEND and MERLON. During the ENKORE cluster lifespan, just a total of three newsletters will be sent with cluster […]

ENKORE cluster website open
ENKORE is a cluster on endocrine disrupting chemicals and knowledge on health-related effects. The website of the cluster is now open! ENKORE is a cluster of five research projects from the call HORIZON-HLTH-2023-ENVHLTH-02-03 “Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties”. The cluster aims to strengthen collaboration, avoid duplication and […]

Hello from the coordinator: Embarking on a Journey of Innovation
NEMESIS was created with the vision of identifying metabolism disrupting chemicals (MDCs) causing adverse metabolic effects and increasing mechanistic understanding of adverse metabolic effects of MDCs in liver, pancreas, and microbiota. Ultimately, the NEMESIS aims to develop novel effect biomarkers for metabolic disruptors, providing evidence on their health impacts. With a consortium of 14 partners […]

ENKORE Cluster kick-off in Brussels
Last Friday we kicked-off the new ENKORE Cluster in Brussels. The ENKORE Cluster consists of five research projects funded by the Horizon Europe programme, to study endocrine disrupting chemicals. We are very excited to get the cluster activities going with our sister-projects MERLON, HYPIEND, EDC-MASLD and ENDOMIX!

NEMESIS project meeting in Helsinki 23-24 May 2024
Finally the NEMESIS consortium members met in person! The first face-to-face NEMESIS project meeting was arranged in sunny Helsinki on 23 – 24 May 2024. Thirty scientists gathered together to work, present and discuss the tasks, progress, and plans of the work packages and the project as a whole.
We are in Instagram
Going social! The NEMESIS project is now in Instagram – go follow us.

Kick-off!
Exciting! The NEMESIS kick-off meeting took place online on 23 and 26 February 2024.
We are in LinkedIn
The NEMESIS project is now in LinkedIn – go follow us to stay updated!